Review



o nitrophenyl β d galactopyranoside  (Chem Impex International)


Bioz Verified Symbol Chem Impex International is a verified supplier
Bioz Manufacturer Symbol Chem Impex International manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 95
      Buy from Supplier

    Structured Review

    Chem Impex International o nitrophenyl β d galactopyranoside
    O Nitrophenyl β D Galactopyranoside, supplied by Chem Impex International, used in various techniques. Bioz Stars score: 95/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/00238/2-Nitrophenyl-b-D-galactopyranoside/pmc07115131-138-5-10
    Average 95 stars, based on 2 article reviews
    o nitrophenyl β d galactopyranoside - by Bioz Stars, 2026-09
    95/100 stars

    Images

    Related Articles

    other:

    Article Title: Agonistic and Antagonistic Effects of Progesterone Derivatives on the Transcriptional Activity of Nuclear Progesterone Receptor B in Yeast Model System
    Article Snippet: Identification of progesterone selective agonists and antagonists that act through one of the nuclear progesterone receptor isoforms is of particular importance for the development of tissue specific drugs in gynecology and anticancer ther apy.. Fourteen pregna D′6 and pregna D′3 pentarane progesterone derivatives with 16α,17α cycloalkane groups and two progesterone 3 deoxyderivatives were examined for their ability to regulate transcriptional activity of human nuclear prog esterone receptor isoform B (nPR B) expressed in Saccharomyces cerevisiae yeast.. Transcriptional activity of nPR B was measured from the expression of the β galactosidase reporter gene with a hormone responsible element in the promoter.

    MTT Assay:

    Article Title: Bioresponsive peptide-polysaccharide nanogels - A versatile delivery system to augment the utility of bioactive cargo.
    Article Snippet: .. Vancomycin hydrochloride, MTT powder and o-nitrophenyl-βD-galactopyranoside were purchased from Chem-Impex (Wood Dale, IL). .. Doxorubicin hydrochloride was purchased from Oakwood Chemical (Estill, SC).

    Article Title: Bioresponsive Peptide-Polysaccharide Nanogels – A Versatile Delivery System to Augment the Utility of Bioactive Cargo
    Article Snippet: 0.1% (w/v) poly-L-lysine (x=400) was purchased from Alamanda Polymers (Huntsville, AL). .. Vancomycin hydrochloride, MTT powder and o -nitrophenyl-β-D-galactopyranoside were purchased from Chem-Impex (Wood Dale, IL). .. Doxorubicin hydrochloride was purchased from Oakwood Chemical (Estill, SC).



    Similar Products

    capnocytophaga ochracea mccm 00238 a3 rm  (ATCC)
    96
    ATCC capnocytophaga ochracea mccm 00238 a3 rm
    Dot blot hybridizations of identical membranes with group-specific probe TRE I (a) and species-specific probe TVIN (b). The strains were kindly provided by R. Mutters, Marburg, Germany (identified as RM); C. Wyss, Zürich, Switzerland (identified as CW); and B. Wilske, Munich, Germany (identified as BW). In columns 1 to 8 PCR products of the following strains were applied as controls: the putative oral pathogens Actinobacillus actinomycetemcomitans MCCM 02638 (A1) (RM), <t>Capnocytophaga</t> gingivalis MCCM 00858 (A2), (RM), Capnocytophaga ochracea <t>MCCM</t> <t>00238</t> (A3) (RM), Eubacterium lentum ATCC 25559T (A4) (RM), Fusobacterium nucleatum ATCC 25586T (A5) (RM), Porphyromonas gingivalis ATCC 33277 (A6) (RM), and Prevotella intermedia MCCM 00407 (A7) (RM); the cultivable treponema species T. vincentii ATCC 35580 (B1), T. denticola ATCC 35405T (B2), T. socranskii subsp. socranskii ATCC 35536 (B3), T. socranskii subsp. buccale ATCC 35534 (B4), T. maltophilum ATCC 51939T (B5) (CW), and T. phagedenis subsp. reiterii (B6) (BW); a clinical isolate (CW) (B8; highest degree of homology to clone NZM 3142), and T. pectinovorum ATCC 33768T (E1); group I recombinant clones NZM3D292 (C1), NZM3D464 (C5), NZM3112 (C6; sequence 100% homologue to probe TVIN), NZM3142 (D2), NZM3147 (D4), and NZM3166 (D7); group II recombinant clones NZM3106 (C7) and NZM3158 (D6); group III recombinant clones NZM3143 (D3), NZM3D298 (C3), and NZM3D527 (C4); group IV recombinant clones NZM3122 (C8), NZM3D505 (C2), and NZM3125 (D8); group V recombinant clones NZM3124 (D1) and NZM3155 (D5); the group VI recombinant clone NZM3104 (E2); and the group VII recombinant clone NZM3D384 (E3). In columns 9 to 15 PCR products from subgingival plaque samples were applied: lanes A to D, PCR products from deep periodontal pockets; lane E, PCR products from the respective controls.
    Capnocytophaga Ochracea Mccm 00238 A3 Rm, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/00238/A3/pmc00104836-186-31-39
    Average 96 stars, based on 1 article reviews
    capnocytophaga ochracea mccm 00238 a3 rm - by Bioz Stars, 2026-09
    96/100 stars
    		  Buy from Supplier
    human il 2 r gamma cd132 protein  (TargetMol)
    94
    TargetMol human il 2 r gamma cd132 protein
    Dot blot hybridizations of identical membranes with group-specific probe TRE I (a) and species-specific probe TVIN (b). The strains were kindly provided by R. Mutters, Marburg, Germany (identified as RM); C. Wyss, Zürich, Switzerland (identified as CW); and B. Wilske, Munich, Germany (identified as BW). In columns 1 to 8 PCR products of the following strains were applied as controls: the putative oral pathogens Actinobacillus actinomycetemcomitans MCCM 02638 (A1) (RM), <t>Capnocytophaga</t> gingivalis MCCM 00858 (A2), (RM), Capnocytophaga ochracea <t>MCCM</t> <t>00238</t> (A3) (RM), Eubacterium lentum ATCC 25559T (A4) (RM), Fusobacterium nucleatum ATCC 25586T (A5) (RM), Porphyromonas gingivalis ATCC 33277 (A6) (RM), and Prevotella intermedia MCCM 00407 (A7) (RM); the cultivable treponema species T. vincentii ATCC 35580 (B1), T. denticola ATCC 35405T (B2), T. socranskii subsp. socranskii ATCC 35536 (B3), T. socranskii subsp. buccale ATCC 35534 (B4), T. maltophilum ATCC 51939T (B5) (CW), and T. phagedenis subsp. reiterii (B6) (BW); a clinical isolate (CW) (B8; highest degree of homology to clone NZM 3142), and T. pectinovorum ATCC 33768T (E1); group I recombinant clones NZM3D292 (C1), NZM3D464 (C5), NZM3112 (C6; sequence 100% homologue to probe TVIN), NZM3142 (D2), NZM3147 (D4), and NZM3166 (D7); group II recombinant clones NZM3106 (C7) and NZM3158 (D6); group III recombinant clones NZM3143 (D3), NZM3D298 (C3), and NZM3D527 (C4); group IV recombinant clones NZM3122 (C8), NZM3D505 (C2), and NZM3125 (D8); group V recombinant clones NZM3124 (D1) and NZM3155 (D5); the group VI recombinant clone NZM3104 (E2); and the group VII recombinant clone NZM3D384 (E3). In columns 9 to 15 PCR products from subgingival plaque samples were applied: lanes A to D, PCR products from deep periodontal pockets; lane E, PCR products from the respective controls.
    Human Il 2 R Gamma Cd132 Protein, supplied by TargetMol, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/00238/IL-2+R+gamma-CD132+Protein%2C+Human%2C+Recombinant/pm41564868-279-179-202
    Average 94 stars, based on 1 article reviews
    human il 2 r gamma cd132 protein - by Bioz Stars, 2026-09
    94/100 stars
    		  Buy from Supplier
    antibodies against lrp11  (Novus Biologicals)
    92
    Novus Biologicals antibodies against lrp11
    Dot blot hybridizations of identical membranes with group-specific probe TRE I (a) and species-specific probe TVIN (b). The strains were kindly provided by R. Mutters, Marburg, Germany (identified as RM); C. Wyss, Zürich, Switzerland (identified as CW); and B. Wilske, Munich, Germany (identified as BW). In columns 1 to 8 PCR products of the following strains were applied as controls: the putative oral pathogens Actinobacillus actinomycetemcomitans MCCM 02638 (A1) (RM), <t>Capnocytophaga</t> gingivalis MCCM 00858 (A2), (RM), Capnocytophaga ochracea <t>MCCM</t> <t>00238</t> (A3) (RM), Eubacterium lentum ATCC 25559T (A4) (RM), Fusobacterium nucleatum ATCC 25586T (A5) (RM), Porphyromonas gingivalis ATCC 33277 (A6) (RM), and Prevotella intermedia MCCM 00407 (A7) (RM); the cultivable treponema species T. vincentii ATCC 35580 (B1), T. denticola ATCC 35405T (B2), T. socranskii subsp. socranskii ATCC 35536 (B3), T. socranskii subsp. buccale ATCC 35534 (B4), T. maltophilum ATCC 51939T (B5) (CW), and T. phagedenis subsp. reiterii (B6) (BW); a clinical isolate (CW) (B8; highest degree of homology to clone NZM 3142), and T. pectinovorum ATCC 33768T (E1); group I recombinant clones NZM3D292 (C1), NZM3D464 (C5), NZM3112 (C6; sequence 100% homologue to probe TVIN), NZM3142 (D2), NZM3147 (D4), and NZM3166 (D7); group II recombinant clones NZM3106 (C7) and NZM3158 (D6); group III recombinant clones NZM3143 (D3), NZM3D298 (C3), and NZM3D527 (C4); group IV recombinant clones NZM3122 (C8), NZM3D505 (C2), and NZM3125 (D8); group V recombinant clones NZM3124 (D1) and NZM3155 (D5); the group VI recombinant clone NZM3104 (E2); and the group VII recombinant clone NZM3D384 (E3). In columns 9 to 15 PCR products from subgingival plaque samples were applied: lanes A to D, PCR products from deep periodontal pockets; lane E, PCR products from the respective controls.
    Antibodies Against Lrp11, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/00238/LRP-11+Antibody/pm39243917-124-32-37
    Average 92 stars, based on 1 article reviews
    antibodies against lrp11 - by Bioz Stars, 2026-09
    92/100 stars
    		  Buy from Supplier
    human bone marrow-derived mesenchymal stromal cells (mscs, lot# 00238)  (RoosterBio)
    90
    RoosterBio human bone marrow-derived mesenchymal stromal cells (mscs, lot# 00238)
    Dot blot hybridizations of identical membranes with group-specific probe TRE I (a) and species-specific probe TVIN (b). The strains were kindly provided by R. Mutters, Marburg, Germany (identified as RM); C. Wyss, Zürich, Switzerland (identified as CW); and B. Wilske, Munich, Germany (identified as BW). In columns 1 to 8 PCR products of the following strains were applied as controls: the putative oral pathogens Actinobacillus actinomycetemcomitans MCCM 02638 (A1) (RM), <t>Capnocytophaga</t> gingivalis MCCM 00858 (A2), (RM), Capnocytophaga ochracea <t>MCCM</t> <t>00238</t> (A3) (RM), Eubacterium lentum ATCC 25559T (A4) (RM), Fusobacterium nucleatum ATCC 25586T (A5) (RM), Porphyromonas gingivalis ATCC 33277 (A6) (RM), and Prevotella intermedia MCCM 00407 (A7) (RM); the cultivable treponema species T. vincentii ATCC 35580 (B1), T. denticola ATCC 35405T (B2), T. socranskii subsp. socranskii ATCC 35536 (B3), T. socranskii subsp. buccale ATCC 35534 (B4), T. maltophilum ATCC 51939T (B5) (CW), and T. phagedenis subsp. reiterii (B6) (BW); a clinical isolate (CW) (B8; highest degree of homology to clone NZM 3142), and T. pectinovorum ATCC 33768T (E1); group I recombinant clones NZM3D292 (C1), NZM3D464 (C5), NZM3112 (C6; sequence 100% homologue to probe TVIN), NZM3142 (D2), NZM3147 (D4), and NZM3166 (D7); group II recombinant clones NZM3106 (C7) and NZM3158 (D6); group III recombinant clones NZM3143 (D3), NZM3D298 (C3), and NZM3D527 (C4); group IV recombinant clones NZM3122 (C8), NZM3D505 (C2), and NZM3125 (D8); group V recombinant clones NZM3124 (D1) and NZM3155 (D5); the group VI recombinant clone NZM3104 (E2); and the group VII recombinant clone NZM3D384 (E3). In columns 9 to 15 PCR products from subgingival plaque samples were applied: lanes A to D, PCR products from deep periodontal pockets; lane E, PCR products from the respective controls.
    Human Bone Marrow Derived Mesenchymal Stromal Cells (Mscs, Lot# 00238), supplied by RoosterBio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/00238/human+bone+marrow+derived+mscs/pmc09899907-35-0-9
    Average 90 stars, based on 1 article reviews
    human bone marrow-derived mesenchymal stromal cells (mscs, lot# 00238) - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    human bone marrow-derived mesenchymal stromal cells mscs lot# 00238  (RoosterBio)
    90
    RoosterBio human bone marrow-derived mesenchymal stromal cells mscs lot# 00238
    Dot blot hybridizations of identical membranes with group-specific probe TRE I (a) and species-specific probe TVIN (b). The strains were kindly provided by R. Mutters, Marburg, Germany (identified as RM); C. Wyss, Zürich, Switzerland (identified as CW); and B. Wilske, Munich, Germany (identified as BW). In columns 1 to 8 PCR products of the following strains were applied as controls: the putative oral pathogens Actinobacillus actinomycetemcomitans MCCM 02638 (A1) (RM), <t>Capnocytophaga</t> gingivalis MCCM 00858 (A2), (RM), Capnocytophaga ochracea <t>MCCM</t> <t>00238</t> (A3) (RM), Eubacterium lentum ATCC 25559T (A4) (RM), Fusobacterium nucleatum ATCC 25586T (A5) (RM), Porphyromonas gingivalis ATCC 33277 (A6) (RM), and Prevotella intermedia MCCM 00407 (A7) (RM); the cultivable treponema species T. vincentii ATCC 35580 (B1), T. denticola ATCC 35405T (B2), T. socranskii subsp. socranskii ATCC 35536 (B3), T. socranskii subsp. buccale ATCC 35534 (B4), T. maltophilum ATCC 51939T (B5) (CW), and T. phagedenis subsp. reiterii (B6) (BW); a clinical isolate (CW) (B8; highest degree of homology to clone NZM 3142), and T. pectinovorum ATCC 33768T (E1); group I recombinant clones NZM3D292 (C1), NZM3D464 (C5), NZM3112 (C6; sequence 100% homologue to probe TVIN), NZM3142 (D2), NZM3147 (D4), and NZM3166 (D7); group II recombinant clones NZM3106 (C7) and NZM3158 (D6); group III recombinant clones NZM3143 (D3), NZM3D298 (C3), and NZM3D527 (C4); group IV recombinant clones NZM3122 (C8), NZM3D505 (C2), and NZM3125 (D8); group V recombinant clones NZM3124 (D1) and NZM3155 (D5); the group VI recombinant clone NZM3104 (E2); and the group VII recombinant clone NZM3D384 (E3). In columns 9 to 15 PCR products from subgingival plaque samples were applied: lanes A to D, PCR products from deep periodontal pockets; lane E, PCR products from the respective controls.
    Human Bone Marrow Derived Mesenchymal Stromal Cells Mscs Lot# 00238, supplied by RoosterBio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/00238/human+bone+marrow+derived+mscs/pm36756385-61-0-9
    Average 90 stars, based on 1 article reviews
    human bone marrow-derived mesenchymal stromal cells mscs lot# 00238 - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    o nitrophenyl β d galactopyranoside  (Chem Impex International)
    95
    Chem Impex International o nitrophenyl β d galactopyranoside
    Dot blot hybridizations of identical membranes with group-specific probe TRE I (a) and species-specific probe TVIN (b). The strains were kindly provided by R. Mutters, Marburg, Germany (identified as RM); C. Wyss, Zürich, Switzerland (identified as CW); and B. Wilske, Munich, Germany (identified as BW). In columns 1 to 8 PCR products of the following strains were applied as controls: the putative oral pathogens Actinobacillus actinomycetemcomitans MCCM 02638 (A1) (RM), <t>Capnocytophaga</t> gingivalis MCCM 00858 (A2), (RM), Capnocytophaga ochracea <t>MCCM</t> <t>00238</t> (A3) (RM), Eubacterium lentum ATCC 25559T (A4) (RM), Fusobacterium nucleatum ATCC 25586T (A5) (RM), Porphyromonas gingivalis ATCC 33277 (A6) (RM), and Prevotella intermedia MCCM 00407 (A7) (RM); the cultivable treponema species T. vincentii ATCC 35580 (B1), T. denticola ATCC 35405T (B2), T. socranskii subsp. socranskii ATCC 35536 (B3), T. socranskii subsp. buccale ATCC 35534 (B4), T. maltophilum ATCC 51939T (B5) (CW), and T. phagedenis subsp. reiterii (B6) (BW); a clinical isolate (CW) (B8; highest degree of homology to clone NZM 3142), and T. pectinovorum ATCC 33768T (E1); group I recombinant clones NZM3D292 (C1), NZM3D464 (C5), NZM3112 (C6; sequence 100% homologue to probe TVIN), NZM3142 (D2), NZM3147 (D4), and NZM3166 (D7); group II recombinant clones NZM3106 (C7) and NZM3158 (D6); group III recombinant clones NZM3143 (D3), NZM3D298 (C3), and NZM3D527 (C4); group IV recombinant clones NZM3122 (C8), NZM3D505 (C2), and NZM3125 (D8); group V recombinant clones NZM3124 (D1) and NZM3155 (D5); the group VI recombinant clone NZM3104 (E2); and the group VII recombinant clone NZM3D384 (E3). In columns 9 to 15 PCR products from subgingival plaque samples were applied: lanes A to D, PCR products from deep periodontal pockets; lane E, PCR products from the respective controls.
    O Nitrophenyl β D Galactopyranoside, supplied by Chem Impex International, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/00238/2-Nitrophenyl-b-D-galactopyranoside/pmc07115131-47-5-10
    Average 95 stars, based on 1 article reviews
    o nitrophenyl β d galactopyranoside - by Bioz Stars, 2026-09
    95/100 stars
    		  Buy from Supplier
    o nitrophenyl βd galactopyranoside  (Chem Impex International)
    95
    Chem Impex International o nitrophenyl βd galactopyranoside
    Dot blot hybridizations of identical membranes with group-specific probe TRE I (a) and species-specific probe TVIN (b). The strains were kindly provided by R. Mutters, Marburg, Germany (identified as RM); C. Wyss, Zürich, Switzerland (identified as CW); and B. Wilske, Munich, Germany (identified as BW). In columns 1 to 8 PCR products of the following strains were applied as controls: the putative oral pathogens Actinobacillus actinomycetemcomitans MCCM 02638 (A1) (RM), <t>Capnocytophaga</t> gingivalis MCCM 00858 (A2), (RM), Capnocytophaga ochracea <t>MCCM</t> <t>00238</t> (A3) (RM), Eubacterium lentum ATCC 25559T (A4) (RM), Fusobacterium nucleatum ATCC 25586T (A5) (RM), Porphyromonas gingivalis ATCC 33277 (A6) (RM), and Prevotella intermedia MCCM 00407 (A7) (RM); the cultivable treponema species T. vincentii ATCC 35580 (B1), T. denticola ATCC 35405T (B2), T. socranskii subsp. socranskii ATCC 35536 (B3), T. socranskii subsp. buccale ATCC 35534 (B4), T. maltophilum ATCC 51939T (B5) (CW), and T. phagedenis subsp. reiterii (B6) (BW); a clinical isolate (CW) (B8; highest degree of homology to clone NZM 3142), and T. pectinovorum ATCC 33768T (E1); group I recombinant clones NZM3D292 (C1), NZM3D464 (C5), NZM3112 (C6; sequence 100% homologue to probe TVIN), NZM3142 (D2), NZM3147 (D4), and NZM3166 (D7); group II recombinant clones NZM3106 (C7) and NZM3158 (D6); group III recombinant clones NZM3143 (D3), NZM3D298 (C3), and NZM3D527 (C4); group IV recombinant clones NZM3122 (C8), NZM3D505 (C2), and NZM3125 (D8); group V recombinant clones NZM3124 (D1) and NZM3155 (D5); the group VI recombinant clone NZM3104 (E2); and the group VII recombinant clone NZM3D384 (E3). In columns 9 to 15 PCR products from subgingival plaque samples were applied: lanes A to D, PCR products from deep periodontal pockets; lane E, PCR products from the respective controls.
    O Nitrophenyl βd Galactopyranoside, supplied by Chem Impex International, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/00238/2-Nitrophenyl-b-D-galactopyranoside/pm30399437-33-5-9
    Average 95 stars, based on 1 article reviews
    o nitrophenyl βd galactopyranoside - by Bioz Stars, 2026-09
    95/100 stars
    		  Buy from Supplier
    ortho nitrophenyl β galactopyranoside onpg  (Chem Impex International)
    95
    Chem Impex International ortho nitrophenyl β galactopyranoside onpg
    Dot blot hybridizations of identical membranes with group-specific probe TRE I (a) and species-specific probe TVIN (b). The strains were kindly provided by R. Mutters, Marburg, Germany (identified as RM); C. Wyss, Zürich, Switzerland (identified as CW); and B. Wilske, Munich, Germany (identified as BW). In columns 1 to 8 PCR products of the following strains were applied as controls: the putative oral pathogens Actinobacillus actinomycetemcomitans MCCM 02638 (A1) (RM), <t>Capnocytophaga</t> gingivalis MCCM 00858 (A2), (RM), Capnocytophaga ochracea <t>MCCM</t> <t>00238</t> (A3) (RM), Eubacterium lentum ATCC 25559T (A4) (RM), Fusobacterium nucleatum ATCC 25586T (A5) (RM), Porphyromonas gingivalis ATCC 33277 (A6) (RM), and Prevotella intermedia MCCM 00407 (A7) (RM); the cultivable treponema species T. vincentii ATCC 35580 (B1), T. denticola ATCC 35405T (B2), T. socranskii subsp. socranskii ATCC 35536 (B3), T. socranskii subsp. buccale ATCC 35534 (B4), T. maltophilum ATCC 51939T (B5) (CW), and T. phagedenis subsp. reiterii (B6) (BW); a clinical isolate (CW) (B8; highest degree of homology to clone NZM 3142), and T. pectinovorum ATCC 33768T (E1); group I recombinant clones NZM3D292 (C1), NZM3D464 (C5), NZM3112 (C6; sequence 100% homologue to probe TVIN), NZM3142 (D2), NZM3147 (D4), and NZM3166 (D7); group II recombinant clones NZM3106 (C7) and NZM3158 (D6); group III recombinant clones NZM3143 (D3), NZM3D298 (C3), and NZM3D527 (C4); group IV recombinant clones NZM3122 (C8), NZM3D505 (C2), and NZM3125 (D8); group V recombinant clones NZM3124 (D1) and NZM3155 (D5); the group VI recombinant clone NZM3104 (E2); and the group VII recombinant clone NZM3D384 (E3). In columns 9 to 15 PCR products from subgingival plaque samples were applied: lanes A to D, PCR products from deep periodontal pockets; lane E, PCR products from the respective controls.
    Ortho Nitrophenyl β Galactopyranoside Onpg, supplied by Chem Impex International, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/00238/2-Nitrophenyl-b-D-galactopyranoside/10__1134_slash_s0006297918050103-46-72-77
    Average 95 stars, based on 1 article reviews
    ortho nitrophenyl β galactopyranoside onpg - by Bioz Stars, 2026-09
    95/100 stars
    		  Buy from Supplier

    Image Search Results


    Dot blot hybridizations of identical membranes with group-specific probe TRE I (a) and species-specific probe TVIN (b). The strains were kindly provided by R. Mutters, Marburg, Germany (identified as RM); C. Wyss, Zürich, Switzerland (identified as CW); and B. Wilske, Munich, Germany (identified as BW). In columns 1 to 8 PCR products of the following strains were applied as controls: the putative oral pathogens Actinobacillus actinomycetemcomitans MCCM 02638 (A1) (RM), Capnocytophaga gingivalis MCCM 00858 (A2), (RM), Capnocytophaga ochracea MCCM 00238 (A3) (RM), Eubacterium lentum ATCC 25559T (A4) (RM), Fusobacterium nucleatum ATCC 25586T (A5) (RM), Porphyromonas gingivalis ATCC 33277 (A6) (RM), and Prevotella intermedia MCCM 00407 (A7) (RM); the cultivable treponema species T. vincentii ATCC 35580 (B1), T. denticola ATCC 35405T (B2), T. socranskii subsp. socranskii ATCC 35536 (B3), T. socranskii subsp. buccale ATCC 35534 (B4), T. maltophilum ATCC 51939T (B5) (CW), and T. phagedenis subsp. reiterii (B6) (BW); a clinical isolate (CW) (B8; highest degree of homology to clone NZM 3142), and T. pectinovorum ATCC 33768T (E1); group I recombinant clones NZM3D292 (C1), NZM3D464 (C5), NZM3112 (C6; sequence 100% homologue to probe TVIN), NZM3142 (D2), NZM3147 (D4), and NZM3166 (D7); group II recombinant clones NZM3106 (C7) and NZM3158 (D6); group III recombinant clones NZM3143 (D3), NZM3D298 (C3), and NZM3D527 (C4); group IV recombinant clones NZM3122 (C8), NZM3D505 (C2), and NZM3125 (D8); group V recombinant clones NZM3124 (D1) and NZM3155 (D5); the group VI recombinant clone NZM3104 (E2); and the group VII recombinant clone NZM3D384 (E3). In columns 9 to 15 PCR products from subgingival plaque samples were applied: lanes A to D, PCR products from deep periodontal pockets; lane E, PCR products from the respective controls.

    Journal:

    Article Title: Molecular Epidemiology of Oral Treponemes Associated with Periodontal Disease

    doi:

    Figure Lengend Snippet: Dot blot hybridizations of identical membranes with group-specific probe TRE I (a) and species-specific probe TVIN (b). The strains were kindly provided by R. Mutters, Marburg, Germany (identified as RM); C. Wyss, Zürich, Switzerland (identified as CW); and B. Wilske, Munich, Germany (identified as BW). In columns 1 to 8 PCR products of the following strains were applied as controls: the putative oral pathogens Actinobacillus actinomycetemcomitans MCCM 02638 (A1) (RM), Capnocytophaga gingivalis MCCM 00858 (A2), (RM), Capnocytophaga ochracea MCCM 00238 (A3) (RM), Eubacterium lentum ATCC 25559T (A4) (RM), Fusobacterium nucleatum ATCC 25586T (A5) (RM), Porphyromonas gingivalis ATCC 33277 (A6) (RM), and Prevotella intermedia MCCM 00407 (A7) (RM); the cultivable treponema species T. vincentii ATCC 35580 (B1), T. denticola ATCC 35405T (B2), T. socranskii subsp. socranskii ATCC 35536 (B3), T. socranskii subsp. buccale ATCC 35534 (B4), T. maltophilum ATCC 51939T (B5) (CW), and T. phagedenis subsp. reiterii (B6) (BW); a clinical isolate (CW) (B8; highest degree of homology to clone NZM 3142), and T. pectinovorum ATCC 33768T (E1); group I recombinant clones NZM3D292 (C1), NZM3D464 (C5), NZM3112 (C6; sequence 100% homologue to probe TVIN), NZM3142 (D2), NZM3147 (D4), and NZM3166 (D7); group II recombinant clones NZM3106 (C7) and NZM3158 (D6); group III recombinant clones NZM3143 (D3), NZM3D298 (C3), and NZM3D527 (C4); group IV recombinant clones NZM3122 (C8), NZM3D505 (C2), and NZM3125 (D8); group V recombinant clones NZM3124 (D1) and NZM3155 (D5); the group VI recombinant clone NZM3104 (E2); and the group VII recombinant clone NZM3D384 (E3). In columns 9 to 15 PCR products from subgingival plaque samples were applied: lanes A to D, PCR products from deep periodontal pockets; lane E, PCR products from the respective controls.

    Article Snippet: In columns 1 to 8 PCR products of the following strains were applied as controls: the putative oral pathogens Actinobacillus actinomycetemcomitans MCCM 02638 (A1) (RM), Capnocytophaga gingivalis MCCM 00858 (A2), (RM), Capnocytophaga ochracea MCCM 00238 (A3) (RM), Eubacterium lentum ATCC 25559 T (A4) (RM), Fusobacterium nucleatum ATCC 25586 T (A5) (RM), Porphyromonas gingivalis ATCC 33277 (A6) (RM), and Prevotella intermedia MCCM 00407 (A7) (RM); the cultivable treponema species T. vincentii ATCC 35580 (B1), T. denticola ATCC 35405 T (B2), T. socranskii subsp. socranskii ATCC 35536 (B3), T. socranskii subsp. buccale ATCC 35534 (B4), T. maltophilum ATCC 51939 T (B5) (CW), and T. phagedenis subsp. reiterii (B6) (BW); a clinical isolate (CW) (B8; highest degree of homology to clone NZM 3142), and T. pectinovorum ATCC 33768 T (E1); group I recombinant clones NZM3D292 (C1), NZM3D464 (C5), NZM3112 (C6; sequence 100% homologue to probe TVIN), NZM3142 (D2), NZM3147 (D4), and NZM3166 (D7); group II recombinant clones NZM3106 (C7) and NZM3158 (D6); group III recombinant clones NZM3143 (D3), NZM3D298 (C3), and NZM3D527 (C4); group IV recombinant clones NZM3122 (C8), NZM3D505 (C2), and NZM3125 (D8); group V recombinant clones NZM3124 (D1) and NZM3155 (D5); the group VI recombinant clone NZM3104 (E2); and the group VII recombinant clone NZM3D384 (E3).

    Techniques: Dot Blot, Recombinant, Clone Assay, Sequencing